ALSERepository of Iași University of Life Sciences, ROMANIA

Biochemical role of pomegranate molasses in modulation and treatment of hyperlipidemia associated with hyperglycemia

Show simple item record

dc.contributor.author Abou Zaid, Omayma A.R.
dc.contributor.author El Sonbaty, Sawsanm
dc.contributor.author Hamam, Neama M.A.
dc.date.accessioned 2021-07-05T11:22:03Z
dc.date.available 2021-07-05T11:22:03Z
dc.date.issued 2016
dc.identifier.citation Abou Zaid, Omayma A.R., Sawsan M.EL.Sonbaty, Neama M.A. Hamam. 2016. "Biochemical role of pomegranate molasses in modulation and treatment of hyperlipidemia associated with hyperglycemia". Lucrări Științifice USAMV-Iași Seria Medicină Veterinară 59 (1): 119-126. en_US
dc.identifier.uri https://repository.iuls.ro/xmlui/handle/20.500.12811/1528
dc.description.abstract Diabetes, when uncontrolled, causes dyslipidemia often followed by atherogenic abnormalities. The present study was aimed to determine the effect of Pomegranate molasses in diabetes-induced dyslipidemia. Diabetes in male rats induced by streptozotocin which showed increase in the treatment by Pomegranate molasses significantly reduced the elevated blood glucose and lipid profile levels. Thus, our study demonstrates that the consumption of Pomegranate molasses as a potential efficient natural therapeutic against induced type I diabetes accompanied with hyperlipidimic rats. Thirty two waster male rats divided into four equal groups of 8 rats. Group Ι (Control group): received no drugs, Group Π (Pomegranate molasses (PM) group): received (500 mg /kg body weight/day) orally for 21 days. Group IIΙ (Streptozotocin (STZ) group): received intramuscular injection once by STZ (40 mg/kg body weight). Group VΙ :( Streptozotocin+ Pomegranate molasses (STZ+ PM)): received intramuscular injection once by STZ (40 mg/kg body weight) and after 3 days received orally PM (500 mg /kg body weight/day) daily. Treatment in groups for 21 days after diabetes induction blood. Blood samples and pancreatic tissue were collected at 22th day from treatment of PM. The obtained results showed that, rats treated with STZ showed a significant increase in glucose concentration with significant decrease in insulin level and G6PD activity. A significant increase in cholesterol, triglyceride, LDL with significant decrease in HDL levels. Also showed significant increase in MDA level and significant decrease in CAT, GPx, SOD activities and GSH level, where the liver enzymes ALT, AST significantly increased. Urea and creatinine (Kidney function) levels showed no significant changes. Animal's body weight was significantly decreased through experimental period. Histological studies of pancreatic tissue showed atrophy and pancreatic tissue damage in island of Langerhans cells. The data obtained shows that PM is potential antidiabeteic natural products and antihyperlipidemic associated with diabetes. en_US
dc.language.iso en en_US
dc.publisher ”Ion Ionescu de la Brad” University of Agricultural Sciences and Veterinary Medicine, Iași en_US
dc.rights Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
dc.rights.uri https://creativecommons.org/licenses/by/4.0/
dc.subject STZ en_US
dc.subject Pomegranate molasses en_US
dc.subject Diabetes en_US
dc.subject Anti-oxidant en_US
dc.title Biochemical role of pomegranate molasses in modulation and treatment of hyperlipidemia associated with hyperglycemia en_US
dc.type Article en_US
dc.author.affiliation Omayma A.R. ABOU ZAID, Department, Faculty of Vet. Med. Moshtohor, Benha University, Egypt
dc.author.affiliation Sawsan M.EL.SONBATY, Radiation Microbiology Dept, National Center for Radiation Research and Technology (NCRRT)
dc.author.affiliation Neama M.A. HAMAM, * Department, Faculty of Vet. Med. Moshtohor, Benha University, Egypt
dc.publicationName Lucrări Științifice USAMV - Iași, Seria Medicină Veterinară
dc.volume 59
dc.issue 1
dc.publicationDate 2016
dc.startingPage 119
dc.endingPage 126
dc.identifier.eissn 2393-4603


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)